Covid-19 vaccine candidate could be with regulators within next four months
The University of Oxford and AstraZeneca’s possible vaccine would then go through a process to make a full assessment of the data
25 August 2020 - 12:27
London — Trial data for the University of Oxford and AstraZeneca’s possible Covid-19 vaccine could be given to regulators in 2020 still, but corners cannot be cut to speed up approval for emergency use, a scientist leading the trials said on Tuesday.
The Oxford vaccine produced an immune response in its first human trials, underlining its position as one of the leading candidates in the race to combat a virus that has led to hundreds of thousands of deaths and crippled the global economy...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.